Revenue segments as reported by the company.

Products

Premiums

Services

Net investment income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Benefit costs

Operating expenses

Goodwill impairment

Store impairments

Opioid litigation charges

Loss on assets held for sale

Restructuring charge

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

CVS Health

Aetna is an American managed health care company, which sells traditional and consumer directed health care insurance plans and related services, such as medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans. Aetna is a member of the Fortune 500.

Aetna

CVS Pharmacy is a subsidiary of the American retail and health care company CVS Health, headquartered in Woonsocket, Rhode Island. It was also known as, and originally named the Consumer Value Store and was founded in Lowell, Massachusetts, in 1963. The chain was owned by its original holding company Melville Corporation since its inception until its current parent company CVS Health was spun off into its own company in 1996. CVS Pharmacy is currently the largest pharmacy chain in the United States by number of locations (over 9,600 as of 2016) and total prescription revenue. As the retail pharmacy division of CVS Health, it ranks as the 7th largest U.S. corporation according to Fortune 500 in 2016. CVS Pharmacy's leading competitor Walgreens Boots Alliance ranked 37th.

CVS Pharmacy

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

CVS Health exceeds Q4 expectations, eyes growth with Oak Street

CVS Health's strong financial performance in 2022, driven by revenue growth and exceeding EPS expectations, positions the company well for future growth.
The acquisition of Oak Street Health presents opportunities to expand into primary care and improve long-term earnings growth, despite challenges in maintaining retail performance.

CVS Health excels in Q1, eyes growth through acquisitions and innovation

CVS Health's strong financial performance, strategic acquisitions, and customer-centric initiatives position the company for sustained growth and competitive advantage.
While facing challenges in the evolving healthcare landscape, CVS Health's focus on innovation, affordability, and operational efficiency provides a solid foundation for future success.
By capitalizing on opportunities in growth, synergies, and healthcare services, CVS Health can navigate industry headwinds and drive long-term value creation for stakeholders.

CVS Health reports robust Q2 earnings, eyes growth opportunities

CVS Health's Q2 2023 performance reflects strong financial results and strategic acquisitions driving growth.
Despite challenges like higher costs and restructuring charges, the company remains confident in its ability to deliver outstanding performance.
Opportunities lie in expanding Medicaid contracts, biosimilar market establishment, and clinic openings for at-risk populations.
Overall, CVS Health's focus on cost optimization, digital sales growth, and patient engagement positions it well for future success.

CVS Health reports robust Q3 earnings and strategic growth plans

CVS Health's Q3 performance reflects strong financial results and strategic initiatives across its segments, positioning the company for sustainable growth.
While facing challenges like declining vaccine demand and contract losses, CVS Health is focused on leveraging opportunities in biosimilars and cost-saving solutions.
The company's commitment to operational excellence, innovation, and workforce investment underscores its strategic vision for becoming a leading health solutions provider.
With a clear focus on growth drivers and mitigating challenges, CVS Health is poised to capitalize on market opportunities and deliver value to shareholders.

CVS Health reports robust Q4 earnings, eyes Medicare margin recovery

CVS Health's Q4 2023 earnings call highlighted strong financial performance, a cautious stance on Medicare Advantage utilization, and a focus on transforming healthcare delivery. The company is committed to margin recovery, growth, and enhancing customer experience while addressing challenges in Medicare Advantage trends and cost pressures.

CVS Health faces Medicare Advantage challenges, focuses on margin improvement

CVS Health's Q1 2024 earnings call highlighted strong financial performance, challenges in the Medicare Advantage business, and a focus on improving margins. The company showcased strengths in the biosimilar market and Pharmacy & Consumer Wellness segment while addressing issues impacting Health Care Benefits and Services segments.

CVS Health's Q2 2024 performance reflects strong financial results, cost savings, and innovative initiatives in pharmacy services.
The company faces challenges in the Health Care Benefits segment but is actively addressing them through leadership changes and operational improvements.
Opportunities for growth include driving margin improvements, expanding digital reach, and educating stakeholders on the value delivery of PBMs.
Expectation of margin recovery in Medicare Advantage and double-digit EPS growth in 2025 highlight CVS Health's strategic focus on operational efficiencies and cost savings.

CVS Health reports robust Q3 earnings, focuses on growth strategies

CVS Health's Q3 2024 performance was marked by strong financial results, leadership changes, and segment-specific challenges and successes. The company is focused on leveraging opportunities in strategic initiatives and addressing areas for improvement to drive future growth.

Revenue

Cost of revenue

Gross profit

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

The big healthcare company beat its earnings guidance with help from Aetna, higher brand drug prices, and a shift in the Easter holiday.

CVS Health Delivers Strong Second-Quarter Growth Fueled by Its Aetna Acquisition

CVS Health Corporation's (CVS) CEO Larry Merlo on Q2 2019 Results - Earnings Call Transcript

Better-than-expected Q2 results are making investors happy.

Why CVS Health Stock Is Jumping Today

CVS Health Corp  raised its full-year profit forecast and reported higher-than-expected second-quarter results on Wednesday, as increased U.S. prescription drug prices fueled rebates to its pharmacy benefits business.

CVS Health raises 2019 profit forecast after beating profit estimates

CVS Health's (CVS) second-quarter top-line growth in Pharmacy Services segment is backed by an uptick in specialty services.

CVS Health (CVS) Beats on Q2 Earnings, Raises '19 Guidance

CVS stock has rallied off a six-year low after a strong quarter, but growing political headwinds should limit gains.

New CVS Uptrend Unlikely Despite Strong Quarter

CVS Health will open about about one-third of the stores it usually opens this year and even fewer next year, the company's head of retail said Wednesday.

CVS slows store expansion plans, cuts pace by a third

CVS Health (CVS) delivered earnings and revenue surprises of 11.18% and 1.31%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

CVS Health (CVS) Beats Q2 Earnings and Revenue Estimates

CVS Health (NYSE: CVS) shares are trading higher after the company reported better-than-expected second-quarter earnings and sales results.

CVS Health Reports Q2 Earnings Beat, Raises Guidance

Shares of CVS rose 4.6% in premarket trade Wednesday after the drugstore chain reported earnings that topped Wall Street expectations.

CVS stock surges 4.6% after second-quarter earnings beat

CVS hiked its full-year forecast after beating analysts' second-quarter earnings and revenue expectations.

CVS posts big earnings beat, raises full-year forecast

A low subscription price for free fast shipping and other perks? Sounds familiar.

Can a CVS Loyalty Program Compete With Amazon Prime?

CVS Health (CVS) will be reporting their second quarter before the opening bell on Wednesday.

Buy CVS Health (CVS) Ahead of Q2 Earnings?

Amazon

Walgreens

Amazon's PillPack unit is battling CVS and Walgreens over requests to transfer patients to its mail-delivery pharmacy.

Amazon's PillPack is battling with CVS and Walgreens over getting patient prescriptions

CVS Health (NYSE: CVS) announces its next round of earnings this Wednesday, August 7.

CVS Health's Q2 Earnings Preview

CVS CarePass is now available across the U.S. and it offers many benefits to members that sign up for the loyalty program.

CVS CarePass: CVS Free Delivery Program Goes Nationwide

Akin to the previous quarters, net new business and the steady uptake of Maintenance Choice programs are likely to bolster CVS Health's (CVS) PBM business in Q2.

Can Pharmacy Services Drive CVS Health's (CVS) Q2 Earnings?

CVS Health Corp (NYSE: CVS) has a plan to be viewed less as a pharmacy chain and more like Amazon.com, Inc.

How CVS Wants To Be Less Like A Pharmacy Chain And More Like Amazon

CVS CarePass members pay $5 a month or $48 annually for a suite of benefits, including free shipping and discounts.

CVS targets millennials with Amazon-like membership

Look for plenty of good news when the healthcare giant reports its Q2 results on Wednesday.

3 Things You Can Expect With CVS Health's Q2 Earnings Update

American Electric Power Company

Coca-Cola

McDonald's

QUALCOMM

AT&T

Target

With rates set to remain lower for longer, these seven big dividend stocks are due for strong performances.
The post 7 Big Dividend Stocks to Consider In a Low-Rate World appeared first on InvestorPlace.

7 Big Dividend Stocks to Consider In a Low-Rate World

CVS stock is facing multiple headwinds, but CVS stock price has now reached attractive levels ahead of earnings..
The post CVS Stock Is Worth Buying Ahead of Its Earnings appeared first on InvestorPlace.

CVS Stock Is Worth Buying Ahead of Its Earnings

Cronos Group

Disney

The peak of earnings season has passed, but there are still earnings reports next week with large implications for stocks and their sectors.

3 Earnings Reports to Watch Next Week: CRON, CVS & DIS

Within the Health Care Benefits segment, CVS Health (CVS) expects the government programs to go from strength to strength on the back of Medicare growth and major Medicaid wins.

Can All-Line Growth Aid CVS Health's (CVS) Earnings in Q2?

JD.com

Pinduoduo Inc - ADR

Retailers are making prudent investments to strengthen digital ecosystem and bolster shipping and delivery capabilities. While these drive sales, they entail high costs.

News for CVS Health Stock (CVS)